Neuroprotectants in the Era of Reperfusion Therapy

키워드

참고문헌 (124)

1. Jovin TG, "Thrombectomy within 8 hours after symptom onset in ischemic stroke", N Engl J Med, 372, pp.2296~2306 (2015)[DOI]
2. Saver JL, "Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke", N Engl J Med, 372, pp.2285~2295 (2015)[DOI]
3. Goyal M, "Randomized assessment of rapid endovascular treatment of ischemic stroke", N Engl J Med, 372, pp.1019~1030 (2015)[DOI]
4. Campbell BC, "Endovascular therapy for ischemic stroke with perfusion-imaging selection", N Engl J Med, 372, pp.1009~1018 (2015)[DOI]
5. Berkhemer OA, "A randomized trial of intraarterial treatment for acute ischemic stroke", N Engl J Med, 372, pp.11~20 (2015)[DOI]
6. Nogueira RG, "Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct", N Engl J Med, 378, pp.11~21 (2018)[DOI]
7. Feigin VL, "Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010", Lancet, 383, pp.245~254 (2014)[DOI]
8. Gladstone DJ, "Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions", Stroke, 33, pp.2123~2136 (2002)[DOI]
9. Cheng YD, "Neuroprotection for ischemic stroke: two decades of success and failure", NeuroRx, 1, pp.36~45 (2004)[DOI]
10. Savitz SI, "A critique of SAINT II: wishful thinking, dashed hopes, and the future of neuroprotection for acute stroke", Stroke, 39, pp.1389~1391 (2008)[DOI]
11. Chamorro A, "Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and inflammation", Lancet Neurol, 15, pp.869~881 (2016)[DOI]
12. Saver JL, "Prehospital use of magnesium sulfate as neuroprotection in acute stroke", N Engl J Med, 372, pp.528~536 (2015)[DOI]
13. Feuerstein GZ, "Missing steps in the STAIR case: a translational medicine perspective on the development of NXY-059 for treatment of acute ischemic stroke", J Cereb Blood Flow Metab, 28, pp.217~219 (2008)[DOI]
14. Lipton P, "Ischemic cell death in brain neurons", Physiol Rev, 79, pp.1431~1568 (1999)[DOI]
15. Tsai JP, "Reperfusion versus recanalization: the winner is...", Stroke, 46, pp.1433~1434 (2015)[DOI]
16. Amaro S, "Translational stroke research of the combination of thrombolysis and antioxidant therapy", Stroke, 42, pp.1495~1499 (2011)[DOI]
17. Savitz SI, "Reconsidering neuroprotection in the reperfusion era", Stroke, 48, pp.3413~3419 (2017)[DOI]
18. Rha JH, "The impact of recanalization on ischemic stroke outcome: a meta-analysis", Stroke, 38, pp.967~973 (2007)[DOI]
19. Warach S, "Evidence of reperfusion injury, exacerbated by thrombolytic therapy, in human focal brain ischemia using a novel imaging marker of early blood-brain barrier disruption", Stroke, 35(11 Suppl 1), pp.2659~2661 (2004)[DOI]
20. Soares BP, "Reperfusion is a more accurate predictor of follow-up infarct volume than recanalization: a proof of concept using CT in acute ischemic stroke patients", Stroke, 41, pp.e34~e40 (2010)[DOI]
21. Baird AE, "Reperfusion after thrombolytic therapy in ischemic stroke measured by single-photon emission computed tomography", Stroke, 25, pp.79~85 (1994)[DOI]
22. Khatri P, "Revascularization end points in stroke interventional trials: recanalization versus reperfusion in IMS-I", Stroke, 36, pp.2400~2403 (2005)[DOI]
23. Albers GW, "Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study", Ann Neurol, 60, pp.508~517 (2006)[DOI]
24. De Silva DA, "Assessing reperfusion and recanalization as markers of clinical outcomes after intravenous thrombolysis in the echoplanar imaging thrombolytic evaluation trial (EPITHET)", Stroke, 40, pp.2872~2874 (2009)[DOI]
25. Kidwell CS, "Diffusion-perfusion MRI characterization of post-recanalization hyperperfusion in humans", Neurology, 57, pp.2015~2021 (2001)[DOI]
26. Tomsick T, "Revascularization results in the interventional management of stroke II trial", AJNR Am J Neuroradiol, 29, pp.582~587 (2008)[DOI]
27. Khatri P, "Methodology of the interventional management of stroke III trial", Int J Stroke, 3, pp.130~137 (2008)[DOI]
28. Powers WJ, "2015 American Heart Association", American Stroke Association focused update of the 2013 guidelines for the early management of patients with acute ischemic stroke regarding endovascular treatment: a guideline for healthcare professionals from the American Heart Association, Stroke, pp.2015, 46[DOI]
29. Kleine JF, "Time to redefine success? TICI 3 versus TICI 2b recanalization in middle cerebral artery occlusion treated with thrombectomy", J Neurointerv Surg, 9, pp.117~121 (2017)[DOI]
30. Almekhlafi MA, "Not all "successful" angiographic reperfusion patients are an equal validation of a modified TICI scoring system", Interv Neuroradiol, 20, pp.21~27 (2014)[DOI]
31. Dargazanli C, "Impact of modified TICI 3 versus modified TICI 2b reperfusion score to predict good outcome following endovascular therapy", AJNR Am J Neuroradiol, 38, pp.90~96 (2017)[DOI]
32. Yoo AJ, "Refining angiographic biomarkers of revascularization: improving outcome prediction after intra-arterial therapy", Stroke, 44, pp.2509~2512 (2013)[DOI]
33. Linfante I, "Predictors of poor outcome despite recanalization: a multiple regression analysis of the NASA registry", J Neurointerv Surg, 8, pp.224~229 (2016)[DOI]
34. Chamorro A, "Complete reperfusion is required for maximal benefits of mechanical thrombectomy in stroke patients", Sci Rep, 7, pp.11636~ (2017)[DOI]
35. Saver JL, "Time to treatment with endovascular thrombectomy and outcomes from ischemic stroke: a metaanalysis", JAMA, 316, pp.1279~1288 (2016)[DOI]
36. Zlokovic BV, "Neurovascular mechanisms of Alzheimer's neurodegeneration", Trends Neurosci, 28, pp.202~208 (2005)[DOI]
37. Begley DJ, "Structural and functional aspects of the blood-brain barrier", Prog Drug Res, 61, pp.39~78 (2003)
38. Reina-De La Torre F, "Morphological characteristics and distribution pattern of the arterial vessels in human cerebral cortex: a scanning electron microscope study", Anat Rec, 251, pp.87~96 (1998)[DOI]
39. Dalkara T, "Can restoring incomplete microcirculatory reperfusion improve stroke outcome after thrombolysis?", J Cereb Blood Flow Metab, 32, pp.2091~2099 (2012)[DOI]
40. Ames A 3rd, "Cerebral ischemia. II. The no-reflow phenomenon", Am J Pathol, 52, pp.437~453 (1968)
41. Crowell RM, "Impaired microvascular filling after focal cerebral ischemia in the monkey. Modification by treatment", Neurology, 22, pp.500~504 (1972)[DOI]
42. Little JR, "Microcirculatory obstruction in focal cerebral ischemia: an electron microscopic investigation in monkeys", Stroke, 7, pp.25~30 (1976)[DOI]
43. del Zoppo GJ, "Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons", Stroke, 22, pp.1276~1283 (1991)[DOI]
44. Okada Y, "Fibrin contributes to microvascular obstructions and parenchymal changes during early focal cerebral ischemia and reperfusion", Stroke, 25, pp.1847~1853 (1994)[DOI]
45. Busch E, "Reperfusion after thrombolytic therapy of embolic stroke in the rat: magnetic resonance and biochemical imaging", J Cereb Blood Flow Metab, 18, pp.407~418 (1998)[DOI]
46. Heye N, "Microthromboemboli in acute infarcts: analysis of 40 autopsy cases", Stroke, 27, pp.431~434 (1996)[DOI]
47. focal cortical infarction, "J Cereb Blood Flow Metab", 2011, 328~338, 10.1038[DOI]
48. Theilen H, "Gross persistence of capillary plasma perfusion after middle cerebral artery occlusion in the rat brain", J Cereb Blood Flow Metab, 14, pp.1055~1061 (1994)[DOI]
49. Mori E, "Inhibition of polymorphonuclear leukocyte adherence suppresses no-reflow after focal cerebral ischemia in baboons", Stroke, 23, pp.712~718 (1992)[DOI]
50. Choudhri TF, "Reduced microvascular thrombosis and improved outcome in acute murine stroke by inhibiting GP IIb", IIIa receptor-mediated platelet aggregation, 1998, pp.102, 1301~1310
51. Abumiya T, "Integrin alpha(IIb)beta(3) inhibitor preserves microvascular patency in experimental acute focal cerebral ischemia", Stroke, 31, pp.1402~1409 (2000)[DOI]
52. Belayev L, "Albumin therapy of transient focal cerebral ischemia: in vivo analysis of dynamic microvascular responses", Stroke, 33, pp.1077~1084 (2002)[DOI]
53. Ishikawa M, "CD40", CD40 ligand signaling in mouse cerebral microvasculature after focal ischemia, Circulation, pp.2005, 111[DOI]
54. del Zoppo GJ, "Acute anti-inflammatory approaches to ischemic stroke", Ann N Y Acad Sci, 1207, pp.143~148 (2010)[DOI]
55. Adams HP Jr, "Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II)", Stroke, 39, pp.87~99 (2008)[DOI]
56. Enlimomab Acute Stroke Trial Investigators, "Use of anti-ICAM-1 therapy in ischemic stroke: results of the Enlimomab Acute Stroke Trial", Neurology, 57, pp.1428~1434 (2001)[DOI]
57. Krams M, "Acute stroke therapy by inhibition of neutrophils (ASTIN): an adaptive dose-response study of UK-279,276 in acute ischemic stroke", Stroke, 34, pp.2543~2548 (2003)[DOI]
58. Ginsberg MD, "High-dose albumin treatment for acute ischaemic stroke (ALIAS) part 2: a randomised, double-blind, phase 3, placebo-controlled trial", Lancet Neurol, 12, pp.1049~1058 (2013)[DOI]
59. Miller AA, "NADPH oxidase activity and function are profoundly greater in cerebral versus systemic arteries", Circ Res, 97, pp.1055~1062 (2005)[DOI]
60. Kuroda J, "Nox4 is a major source of superoxide production in human brain pericytes", J Vasc Res, 51, pp.429~438 (2014)[DOI]
61. Hall CN, "Capillary pericytes regulate cerebral blood flow in health and disease", Nature, 508, pp.55~60 (2014)[DOI]
62. Yemisci M, "Pericyte contraction induced by oxidative-nitrative stress impairs capillary reflow despite successful opening of an occluded cerebral artery", Nat Med, 15, pp.1031~1037 (2009)[DOI]
63. Puetz V, "Intracranial thrombus extent predicts clinical outcome, final infarct size and hemorrhagic transformation in ischemic stroke: the clot burden score", Int J Stroke, 3, pp.230~236 (2008)[DOI]
64. Halliwell B, "Oxygen radicals and the nervous system", Trends Neurosci, 8, pp.22~26 (1985)[DOI]
65. Sims NR, "Mitochondrial contributions to tissue damage in stroke", Neurochem Int, 40, pp.511~526 (2002)[DOI]
66. Kawano T, "Prostaglandin E2 EP1 receptors: downstream effectors of COX-2 neurotoxicity", Nat Med, 12, pp.225~229 (2006)[DOI]
67. Vallet P, "Neuronal expression of the NADPH oxidase NOX4, and its regulation in mouse experimental brain ischemia", Neuroscience, 132, pp.233~238 (2005)[DOI]
68. Ago T, "NAD(P)H oxidases in rat basilar arterial endothelial cells", Stroke, 36, pp.1040~1046 (2005)[DOI]
69. Kim GW, "Manganese superoxide dismutase deficiency exacerbates cerebral infarction after focal cerebral ischemia", reperfusion in mice: implications for the production and role of superoxide radicals, 2002, pp.33, 809~815
70. Pryor WA, "The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide", Am J Physiol, 268(5), pp.L699~L722 (1995)
71. Beckman JS, "Oxidative damage and tyrosine nitration from peroxynitrite", Chem Res Toxicol, 9, pp.836~844 (1996)[DOI]
72. Fabian RH, "In vivo detection of superoxide anion production by the brain using a cytochrome c electrode", J Cereb Blood Flow Metab, 15, pp.242~247 (1995)[DOI]
73. Becker BF, "Towards the physiological function of uric acid", Free Radic Biol Med, 14, pp.615~631 (1993)[DOI]
74. Squadrito GL, "Reaction of uric acid with peroxynitrite and implications for the mechanism of neuroprotection by uric acid", Arch Biochem Biophys, 376, pp.333~337 (2000)[DOI]
75. Maples KR, "Comparison of the radical trapping ability of PBN, S-PPBN and NXY-059", Free Radic Res, 34, pp.417~426 (2001)[DOI]
76. Amaro S, "A pilot study of dual treatment with recombinant tissue plasminogen activator and uric acid in acute ischemic stroke", Stroke, 38, pp.2173~2175 (2007)[DOI]
77. Romanos E, "Uric acid reduces brain damage and improves the benefits of rt-PA in a rat model of thromboembolic stroke", J Cereb Blood Flow Metab, 27, pp.14~20 (2007)[DOI]
78. Haberman F, "Soluble neuroprotective antioxidant uric acid analogs ameliorate ischemic brain injury in mice", Neuromolecular Med, 9, pp.315~323 (2007)[DOI]
79. Ma YH, "Thioredoxin-1 attenuates post-ischemic neuronal apoptosis via reducing oxidative", nitrative stress, 2012, pp.60, 475~483
80. Onetti Y, "Middle cerebral artery remodeling following transient brain ischemia is linked to early postischemic hyperemia: a target of uric acid treatment", Am J Physiol Heart Circ Physiol, 308, pp.862~874 (2015)[DOI]
81. Chamorro A, "Safety and efficacy of uric acid in patients with acute stroke (URICO-ICTUS): a randomised, double-blind phase 2b", 3 trial, 2014, pp.13, 453~460
82. Llull L, "Uric acid therapy improves clinical outcome in women with acute ischemic stroke", Stroke, 46, pp.2162~2167 (2015)[DOI]
83. Amaro S, "Uric acid improves glucose-driven oxidative stress in human ischemic stroke", Ann Neurol, 77, pp.775~783 (2015)[DOI]
84. Chamorro A, "Uric acid therapy improves the outcomes of stroke patients treated with intravenous tissue plasminogen activator and mechanical thrombectomy", Int J Stroke, 12, pp.377~382 (2017)[DOI]
85. Gwag BJ, "Marked prevention of ischemic brain injury by Neu2000, an NMDA antagonist and antioxidant derived from aspirin and sulfasalazine", J Cereb Blood Flow Metab, 27, pp.1142~1151 (2007)[DOI]
86. Cho SI, "Neu2000, an NR2B-selective, moderate NMDA receptor antagonist and potent spin trapping molecule for stroke", Drug News Perspect, 23, pp.549~556 (2010)[DOI]
87. Lee JM, "The changing landscape of ischaemic brain injury mechanisms", Nature, 399(6738 Suppl), pp.A7~A14 (1999)[DOI]
88. Park UJ, "Blood-derived iron mediates free radical production and neuronal death in the hippocampal CA1 area following transient forebrain ischemia in rat", Acta Neuropathol, 121, pp.459~473 (2011)[DOI]
89. Pulsinelli WA, "Moderate hyperglycemia augments ischemic brain damage: a neuropathologic study in the rat", Neurology, 32, pp.1239~1246 (1982)[DOI]
90. Yip PK, "Effect of plasma glucose on infarct size in focal cerebral ischemiareperfusion", Neurology, 41, pp.899~905 (1991)[DOI]
91. Chopp M, "Global cerebral ischemia and intracellular pH during hyperglycemia and hypoglycemia in cats", Stroke, 19, pp.1383~1387 (1988)[DOI]
92. Lin B, "Brain temperature modulations during global ischemia fail to influence extracellular lactate levels in rats", Stroke, 26, pp.1634~1638 (1995)[DOI]
93. Park WS, "Effects of hyperglycemia or hypoglycemia on brain cell membrane function and energy metabolism during the immediate reoxygenation-reperfusion period after acute transient global hypoxia-ischemia in the newborn piglet", Brain Res, 901, pp.102~108 (2001)[DOI]
94. Tsuruta R, "Hyperglycemia enhances excessive superoxide anion radical generation, oxidative stress, early inflammation, and endothelial injury in forebrain ischemia", reperfusion rats, 2010, pp.1309, 155~163
95. Allen CL, "Antioxidants attenuate hyperglycaemia-mediated brain endothelial cell dysfunction and blood-brain barrier hyperpermeability", Diabetes Obes Metab, 11, pp.480~490 (2009)[DOI]
96. Suh SW, "Glucose and NADPH oxidase drive neuronal superoxide formation in stroke", Ann Neurol, 64, pp.654~663 (2008)[DOI]
97. Ling PR, "Hyperglycemia enhances the cytokine production and oxidative responses to a low but not high dose of endotoxin in rats", Crit Care Med, 33, pp.1084~1089 (2005)[DOI]
98. Perez-Asensio FJ, "Antioxidant CR-6 protects against reperfusion injury after a transient episode of focal brain ischemia in rats", J Cereb Blood Flow Metab, 30, pp.638~652 (2010)[DOI]
99. Sutherland BA, "Neuroprotection for ischaemic stroke: translation from the bench to the bedside", Int J Stroke, 7, pp.407~418 (2012)[DOI]
100. Dikalova AE, "Therapeutic targeting of mitochondrial superoxide in hypertension", Circ Res, 107, pp.106~116 (2010)[DOI]
101. Sumimoto H, "Structure, regulation and evolution of Noxfamily NADPH oxidases that produce reactive oxygen species", FEBS J, 275, pp.3249~3277 (2008)[DOI]
102. Abramov AY, "Three distinct mechanisms generate oxygen free radicals in neurons and contribute to cell death during anoxia and reoxygenation", J Neurosci, 27, pp.1129~1138 (2007)[DOI]
103. Kahles T, "NADPH oxidase plays a central role in blood-brain barrier damage in experimental stroke", Stroke, 38, pp.3000~3006 (2007)[DOI]
104. Green SP, "Induction of gp91-phox, a component of the phagocyte NADPH oxidase, in microglial cells during central nervous system inflammation", J Cereb Blood Flow Metab, 21, pp.374~384 (2001)[DOI]
105. Kahles T, "Which NADPH oxidase isoform is relevant for ischemic stroke? The case for Nox 2", Antioxid Redox Signal, 18, pp.1400~1417 (2013)[DOI]
106. Kleinschnitz C, "Post-stroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegeneration", PLoS Biol, 8, pp.e1000479~ (2010)[DOI]
107. Jackman KA, "Reduction of cerebral infarct volume by apocynin requires pretreatment and is absent in Nox2-deficient mice", Br J Pharmacol, 156, pp.680~688 (2009)[DOI]
108. Arimura K, "Role of NADPH oxidase 4 in brain endothelial cells after Ischemic stroke", Stroke, 43, pp.A2514~ (2012)
109. Nagel S, "Suppression of the inflammatory response by diphenyleneiodonium after transient focal cerebral ischemia", J Neurochem, 123(Suppl 2), pp.98~107 (2012)[DOI]
110. Wind S, "Comparative pharmacology of chemically distinct NADPH oxidase inhibitors", Br J Pharmacol, 161, pp.885~898 (2010)[DOI]
111. Wassmann S, "Cellular antioxidant effects of atorvastatin in vitro and in vivo", Arterioscler Thromb Vasc Biol, 22, pp.300~305 (2002)[DOI]
112. Willmot M, "A systematic review of nitric oxide donors and L-arginine in experimental stroke; effects on infarct size and cerebral blood flow", Nitric Oxide, 12, pp.141~149 (2005)[DOI]
113. Harston GW, "The contribution of L-arginine to the neurotoxicity of recombinant tissue plasminogen activator following cerebral ischemia: a review of rtPA neurotoxicity", J Cereb Blood Flow Metab, 30, pp.1804~1816 (2010)[DOI]
114. Lapchak PA, "A blinded, randomized study of L-arginine in small clot embolized rabbits", Exp Neurol, 266, pp.143~146 (2015)[DOI]
115. Hardingham GE, "Regulation of neuronal oxidative and nitrosative stress by endogenous protective pathways and disease processes", Antioxid Redox Signal, 14, pp.1421~1424 (2011)[DOI]
116. Xu Z, "Neuroprotective role of Nrf2 for retinal ganglion cells in ischemia-reperfusion", J Neurochem, 133, pp.233~241 (2015)[DOI]
117. Chen XM, "Targeting reactive nitrogen species: a promising therapeutic strategy for cerebral ischemia-reperfusion injury", Acta Pharmacol Sin, 34, pp.67~77 (2013)[DOI]
118. Wong CH, "Absence of glutathione peroxidase-1 exacerbates cerebral ischemia-reperfusion injury by reducing post-ischemic microvascular perfusion", J Neurochem, 107, pp.241~252 (2008)[DOI]
119. Bell KF, "CNS peroxiredoxins and their regulation in health and disease", Antioxid Redox Signal, 14, pp.1467~1477 (2011)[DOI]
120. Szabo C, "Peroxynitrite: biochemistry, pathophysiology and development of therapeutics", Nat Rev Drug Discov, 6, pp.662~680 (2007)[DOI]
121. Suofu Y, "Peroxynitrite decomposition catalyst prevents matrix metalloproteinase activation and neurovascular injury after prolonged cerebral ischemia in rats", J Neurochem, 115, pp.1266~1276 (2010)[DOI]
122. Palomares SM, "Peroxynitrite decomposition with FeTMPyP improves plasma-induced vascular dysfunction and infarction during mild but not severe hyperglycemic stroke", J Cereb Blood Flow Metab, 32, pp.1035~1045 (2012)[DOI]
123. Mackensen GB, "Neuroprotection from delayed postischemic administration of a metalloporphyrin catalytic antioxidant", J Neurosci, 21, pp.4582~4592 (2001)[DOI]
124. Sheng H, "Effects of metalloporphyrin catalytic antioxidants in experimental brain ischemia", Free Radic Biol Med, 33, pp.947~961 (2002)[DOI]

관련 논문AI추천